Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Julia Musto

FDA asks drugmaker Eli Lilly for more safety information on its new GLP-1 weight loss pill

A GLP-1 weight loss pill, already on sale in the United States, has hit a regulatory snag.

The Food and Drug Administration has asked U.S. drugmaker Eli Lilly to collect more long-term safety data on its once-daily tablet Foundayo, according to an April 1 letter published by the FDA Tuesday.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.